QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology across North America and Europe.
Flinders University experts have applied machine learning to DNA profiling, forecasting promising new advances in critical ...
Venlo, the Netherlands, Sept. 30, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today ...
Promising new inroads into critical DNA testing has been forecast by Flinders University experts who have applied machine ...
Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology: Venlo, the Netherlands Thursday, October 3, 2024, 14:00 Hrs [IST] Qiagen N.V., a Netherlands-base ...
30, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio ...
Promising new inroads into critical DNA testing has been forecast by Flinders University experts who have applied machine ...
Debatin has collaborated with PreZero on a new packaging solution containing 60% PCR material, with 50% apparently coming from materials collected through the household recycling system, including ...